US stock results analysis for Industry - Specialty Pharmaceuticals for the month ending Jul 31, 2025

Analysis of which US stocks have performed the best and worst in Industry - Specialty Pharmaceuticals for the month ending Jul 31, 2025 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current month are considered.

Stock universe
8
POSITIVE PROFIT GROWTH
7
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
54.4 %
TOTAL REVENUE GROWTH
290.8 %
TOTAL EBIDT GROWTH
65.0 %
TOTAL OPER. PROFIT GROWTH
 Positive  Negative  Pending
Stock Last Result Updated Market Capitalization Current Price Operating Revenue Qtr Revenue Growth Qtr YoY % Revenue Surprise Qtr % Net Profit Qtr Net Profit Qtr Growth YoY % Net Profit Surprise Qtr % Operating Profit Qtr Operating Profit Growth Qtr YoY % EBITDA Qtr EBITDA Qtr growth YoY % Operating Profit Margin Qtr % Operating Profit Qtr Margin% YoY Change
Usana Health Sciences Inc 05-Aug-2025 581.41 31.82 4.73 50.70
Argen X SE ADR 31-Jul-2025 45947.66 750.78 10.76 23.52
Cidara Therapeutics Inc 07-Aug-2025 1601.87 63.17 - 6.03
Niagen Bioscience Inc 06-Aug-2025 750.48 9.41 9.93 668.09
Cronos Group Inc 07-Aug-2025 957.35 2.50 0.66 -544.05
Enveric Biosciences Inc 14-Aug-2025 2.95 0.91 - -
Flora Growth Corp 01-Aug-2025 13.02 22.50 25.74 -119.09
Lifevantage Corporation 04-Sep-2025 157.35 12.11 - -
Mannatech Inc 12-Aug-2025 18.19 9.57 - -
Nature`s Sunshine Products... 31-Jul-2025 302.27 17.14 2.23 75.91
ProPhase Labs Inc 13-Aug-2025 14.95 0.36 -64.79 -
Qualigen Therapeutics Inc 14-Aug-2025 2.87 1.69 - -
Revolution Medicines Inc 06-Aug-2025 7570.79 40.50 - -
FitLife Brands Inc 14-Aug-2025 175.89 18.73 0.31 -
Synergy CHC Corp 14-Aug-2025 25.97 2.32 -24.63 -